Prescient Healthcare Group acquires Uptake
Prescient acquires Uptake, with a focus on exceptional client delivery and impact in the pharmaceutical and biotech industry
Read More
Section: Marketing
Vibrant Therapeutics raises $61m in funding to advance intelligent therapeutics pipeline
The financing includes new investors Pfizer Ventures and Apricot Capital, bringing the total capital raised to $100m
Read More
Vibrant Therapeutics appoints Han Lee as co-CEO
Lee previously held senior roles at ImmPACT Bio, Neogene Therapeutics and AstraZeneca
Read More
NanoSyrinx appoints Thomas J Farrell as CEO
Farrell was previously founder and CEO of two NASDAQ-listed companies
Read More